View Older Stories View More Recent Stories

Aug 5, 2020 04:15PM Veracyte Announces New Real-World Data Reinforcing the Potential Clinical Value of Percepta and Envisia Classifiers to Improve Diagnosis of Serious Lung Diseases
Aug 5, 2020 08:18AM Veracyte (VCYT) Announces Positive Clinical Utility Data for Percepta Classifier Published in CHEST
Aug 5, 2020 08:15AM Veracyte Announces Positive Clinical Utility Data for Percepta Classifier Published in CHEST
Jul 30, 2020 04:05PM Veracyte Announces Second Quarter 2020 Financial Results
Jul 30, 2020 08:15AM Veracyte Announces Data Published in AJRCCM Showing That the Envisia Genomic Classifier Improves Physicians’ Ability to Diagnose IPF Without Surgery
Jul 29, 2020 08:16AM Veracyte (VCYT), MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System
Jul 29, 2020 08:15AM Veracyte and MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System
Jul 27, 2020 08:15AM Veracyte Appoints Jens Holstein to Board of Directors and James (Jim) Erlinger as Executive Vice President, General Counsel and Secretary
Jul 16, 2020 08:15AM Veracyte to Release Second Quarter 2020 Financial Results on July 30, 2020
Jun 11, 2020 07:31AM Veracyte (VCYT) Announces Clinical Utility Study Published in CHEST Demonstrates Envisia Genomic Classifier's Ability to Improve IPF Diagnosis
Jun 11, 2020 07:30AM Veracyte Announces Clinical Utility Study Published in CHEST Demonstrates Envisia Genomic Classifier’s Ability to Improve IPF Diagnosis
Jun 9, 2020 08:15AM Veracyte Announces De Novo Classification Request to FDA for the nCounter Dx LymphMark Assay
May 27, 2020 08:15AM Veracyte to Present at the William Blair 40th Annual Growth Stock Conference
May 21, 2020 08:15AM Veracyte to Present at the Jefferies Virtual Healthcare Conference
May 14, 2020 08:15AM CareDx and Veracyte Announce Exclusive Partnership for Transplant Rejection Testing on nCounter System
May 7, 2020 04:05PM Veracyte to Present at the UBS Virtual Global Healthcare Conference
May 6, 2020 04:05PM Veracyte Announces First Quarter 2020 Financial Results
May 1, 2020 08:15AM Veracyte Launches “More About You” Campaign to Educate Patients About Thyroid Cancer Diagnosis
Apr 23, 2020 08:15AM Veracyte and Yale Announce Exclusive License to Advance First Genomic Monitoring Test for Idiopathic Pulmonary Fibrosis
Apr 23, 2020 08:15AM CORRECTING and REPLACING Veracyte and Yale Announce Exclusive License to Advance First Genomic Monitoring Test for Idiopathic Pulmonary Fibrosis
Apr 16, 2020 04:32PM Veracyte (VCYT) Announces Prelim. Q1 Results, Withdraws 2020 Financial Guidance
Apr 16, 2020 04:30PM Veracyte Announces Preliminary First Quarter 2020 Financial Results and Provides Business Update in Response to COVID-19 Pandemic
Apr 7, 2020 08:15AM Veracyte Names Tracy Morris as Vice President of Corporate Communications and Investor Relations
Apr 1, 2020 08:15AM Veracyte Announces Novel Gene Fusion Detection with the Afirma Xpression Atlas, Which May Inform Targeted Treatment Decisions for Thyroid Cancer Patients
Mar 2, 2020 11:00AM Veracyte Announces Publication of Nearly 700-Patient Study Using Prosigna Breast Cancer Test to Identify Patients Likely to Benefit from Aggressive Chemotherapy
Feb 25, 2020 04:05PM Veracyte Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides 2020 Financial Outlook
Feb 13, 2020 08:15AM Veracyte to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Feb 6, 2020 01:30PM Veracyte to Release Fourth Quarter and Full-Year 2019 Financial Results on February 25, 2020
Jan 8, 2020 08:15AM Veracyte Announces Biopharmaceutical Collaboration with Acerta Pharma
Dec 3, 2019 05:02PM Veracyte (VCYT) Acquires Exclusive License to NanoString (NSTG) Diagnostics Platform
Dec 3, 2019 05:00PM Veracyte Acquires Exclusive License to NanoString Diagnostics Platform, Positioning Veracyte To Expand Its Genomic Testing Business Globally
Nov 2, 2019 09:30AM Veracyte Announces New Data That Advance Understanding of Genomic Alterations Targeted by Precision Medicine Therapies for Thyroid Cancer
Oct 30, 2019 08:18AM Veracyte (VCYT) Announces New Data Characterizing Genomic Alterations in Thyroid Cancer To Be Presented at ATA
Oct 30, 2019 08:15AM Veracyte Announces New Data Characterizing Genomic Alterations in Thyroid Cancer To Be Presented at 89th Annual Meeting of the American Thyroid Association
Oct 22, 2019 04:15PM Veracyte Announces Third Quarter 2019 Financial Results and Business Progress
Oct 22, 2019 07:08AM Veracyte (VCYT) Announces New Clinical Data Showing First-Ever Noninvasive Nasal Swab Test Can Enable Early Lung Cancer Detection and Diagnosis
Oct 22, 2019 07:00AM Veracyte Announces New Clinical Data Showing First-Ever Noninvasive Nasal Swab Test Can Enable Early Lung Cancer Detection and Diagnosis
Oct 21, 2019 04:15PM Veracyte Announces Clinical Data Demonstrating Clinical Validity and Utility of Percepta Classifier in Lung Cancer Diagnosis When Bronchoscopy Results Are Inconclusive
Oct 21, 2019 09:58AM Veracyte (VCYT) Announces New Data Showing Envisia Genomic Classifier Improves IPF Diagnosis
Oct 21, 2019 09:57AM Veracyte Announces New Data Demonstrating That Envisia Genomic Classifier Improves IPF Diagnosis
Oct 8, 2019 04:30PM Veracyte to Release Third Quarter 2019 Financial Results and Business Progress on October 22, 2019
Oct 7, 2019 08:03AM Veracyte (VCYT) to Announce New Clinical Data for First Noninvasive Nasal Swab Test to Target Early Lung Cancer Detection at CHEST
Oct 7, 2019 08:00AM Veracyte to Announce New Clinical Data for First Noninvasive Nasal Swab Test to Target Early Lung Cancer Detection at CHEST Annual Meeting 2019
Sep 11, 2019 11:04AM Veracyte Announces Publication of Clinical and Analytical Validation Data for Afirma Xpression Atlas
Sep 3, 2019 08:16AM Veracyte (VCYT) Reports Publication of New Study Characterizing Gene Alterations in Thyroid Cancer
Sep 3, 2019 08:15AM Veracyte Announces Publication of New Study Characterizing Gene Alterations in Thyroid Cancer
Aug 28, 2019 04:15PM Veracyte to Present at Upcoming Investor Conferences
Jul 30, 2019 04:15PM Veracyte Announces Second Quarter 2019 Financial Results
Jul 1, 2019 08:00AM Veracyte Names Keith Kennedy Chief Operating Officer and Chief Financial Officer
Jun 27, 2019 04:15PM Veracyte to Release Second Quarter 2019 Financial Results on July 30, 2019
View More Recent Stories View Older Stories